Marketplace®

Daily business news and economic stories

India rejects Novartis cancer drug patent

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment called Gleevec — spelled Glivec in some markets. The decision is expected to have a big impact on pharmaceutical companies and health organizations far outside the borders of India.

The BBC’s Rahul Tandon joins Marketplace Morning Report host Jeremy Hobson to discuss the global pharmaceutical market and the new patent ruling.

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    39 minutes ago
    25:59
  • Make Me Smart
    4 hours ago
    19:16
  • Marketplace Morning Report
    8 hours ago
    6:49
  • Marketplace Tech
    13 hours ago
    7:51
  • Million Bazillion
    6 days ago
    26:02
  • How We Survive
    11 days ago
    16:54
  • This Is Uncomfortable
    2 months ago
    37:19
  • Financially Inclined
    2 months ago
    12:30
  • The Uncertain Hour
    4 months ago
    22:50
  • Corner Office from Marketplace
    5 years ago
    20:58